Delivery Order SPE2DE21D7010-SPE2D626F10Y7
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $23,971.86 fixed-price delivery order to Nuvasive, Inc. on October 30, 2025, for the supply of RELINE OPEN IMPLANTS, specialized spinal surgical devices used in orthopedic and neurosurgical procedures. This delivery order, with an ultimate completion date of November 25, 2025, carries no set-aside designation and will be performed at Nuvasive's San Diego, California facility. The contract employs fixed-price pricing with economic...
- The Defense Logistics Agency Medical Supply Chain awarded a $23,598.26 fixed-price delivery order with economic price adjustment to Nuvasive, Inc. for RELINE open implants on August 15, 2025. The contract, which carries no set-aside designation, will be performed in San Diego, California, with an ultimate completion date of September 12, 2025. Nuvasive specializes in advanced spinal surgery products and medical devices, serving as a key supplier to federal healthcare agencies including the...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,646.10 fixed-price delivery order (Contract #4570184048) on December 2, 2025, for RELINE OPEN IMPLANTS. This delivery order, issued without set-aside designation, is funded through the Defense Logistics Agency Medical Supply Chain and includes an economic price adjustment mechanism to address cost fluctuations. Performance is scheduled for completion by December 3,...
- Nuvasive, Inc. was awarded a delivery order valued at $12,607.94 by the Defense Logistics Agency Medical Supply Chain on June 26, 2025, for the procurement of RELINE open implants. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by July 17, 2025, and will be performed at Nuvasive's San Diego, California location. This award was made through open competition with no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,607.94 fixed-price delivery order (contract number 4570040417) by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, for RELINE OPEN IMPLANTS to be delivered by December 5, 2025. The contract was awarded without set-aside designation through open market competition and includes an economic price adjustment mechanism to accommodate cost fluctuations....
- Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a delivery order valued at $31,501.86 on December 11, 2025, for the supply of RELINE-ONE spinal implant products. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of January 2, 2026. This award was issued by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a $13,362.36 fixed-price delivery order (Contract No. 4570340917) on December 10, 2025, for the RELINE-C spinal implant system, with performance scheduled for completion by December 11, 2025, at the company's San Diego, California facility. The contract was funded through the Defense Logistics Agency Medical Supply Chain without set-aside designation, reflecting open competition among qualified medical device suppliers....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order on November 3, 2025, for RELINE MAS IMPLANTS with a ceiling value of $22,376.93 and an ultimate completion date of November 24, 2025. This fixed-price contract with economic price adjustment was issued without set-aside designation by the Defense Logistics Agency Medical Supply Chain, a component of the Department of Defense responsible for procuring medical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, received a $15,686.10 delivery order award from the Defense Logistics Agency (DLA) Medical Supply Chain on June 17, 2025, for RELINE MAS implants. The contract utilizes a fixed-price structure with economic price adjustment provisions and has an ultimate completion date of June 18, 2025. This award was made without set-aside designation, reflecting Nuvasive's competitive success in open...
- The Defense Logistics Agency Medical Supply Chain awarded a $28,748.32 fixed-price delivery order with economic price adjustment to Nuvasive, Inc. for RELINE MAS IMPLANTS on August 28, 2025. The delivery order, which does not utilize a set-aside designation, is scheduled for completion by September 23, 2025, and will be performed in San Diego, California. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, specializes in advanced spinal surgery products and...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F10Y7Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $55,910.77 fixed-price delivery order with economic price adjustment to Nuvasive, Inc. for RELINE OPEN IMPLANTS, specialized spinal surgical devices used in orthopedic and neurosurgical procedures. The contract was issued on December 11, 2025, with an ultimate completion date of January 2, 2026, and will be performed at Nuvasive's San Diego, California facility. This delivery order was issued without set-aside restrictions, demonstrating successful competition in open market procurement. Nuvasive operates as a San Diego-based subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division and specializes in advanced spinal surgery products and services for federal healthcare agencies, including the Department of Defense and Department of Veterans Affairs. This delivery order is issued under the broader $8 million Indefinite Delivery/Indefinite Quantity Blanket Purchase Agreement between Transplant Technology Inc. and the Defense Health Agency, effective through March 2027, which streamlines procurement of spinal medical devices and surgical instruments across military and veteran healthcare facilities nationwide. Nuvasive's product portfolio includes spinal fusion devices, interbody implants, bone graft materials, and specialized surgical instruments. The company maintains an established track record as a critical supplier to the federal healthcare enterprise, with the majority of its contract awards issued by the Defense Logistics Agency Medical Supply Chain, and has demonstrated sustained capability in delivering orthopedic and neurosurgical technologies that support the operational readiness of military and veteran medical systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.9k | 12/10/25 |